Intellia Therapeutics, Inc. (NTLA) vs Pacific Biosciences of Californ (PACB)
Detailed comparison between Intellia Therapeutics, Inc., Pacific Biosciences of Californ.Total Return (%)
Intellia Therapeutics, Inc. (NTLA)Pacific Biosciences of Californ (PACB)
Which stock do you think will perform better?
Intellia Therapeutics, Inc.
NTLA
Pacific Biosciences of Californ
PACB
| Metric | Intellia Therapeutics, Inc. (NTLA) | Pacific Biosciences of Californ (PACB) |
|---|---|---|
| Current Price | $11.51 | $1.63 |
| Change | -0.66 (-5.42%) | 0.09 (5.84%) |
| Market Cap | $1.17B | $0.48B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -2.09 | -2.40 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $34.87 | $6.09 |
| 52-Week Low | $8.96 | $1.16 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-5.45 | $-1.58 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| NTLA | 9.10% | 9.10% | -58.39% | -5.03% | -47.92% | -47.92% |
| PACB | -2.40% | -2.40% | -68.83% | -56.30% | -75.99% | -76.06% |